Home
About
What We Do
Who we are
Advisors
Partners
Our name
Governance
Lived experiences
Products
Products
ProMatrix BioDerm
ProMatrix GroDerm
Pipeline
Products for Research
Wounds & treatments
Skin-loss wounds
How wounds heal
Current wound treatments
Chronic wounds
Technology
Tissue Scaffolds
ProMatrix technology
Manufacturing platform
Modelling & Digital twin
Research Services
SCANNING ELECTRON MICROSCOPY (SEM)
Scaffolds for Research
News
INVESTORS
contact

www.oxartis.co.uk

Home
About
What We Do
Who we are
Advisors
Partners
Our name
Governance
Lived experiences
Products
Products
ProMatrix BioDerm
ProMatrix GroDerm
Pipeline
Products for Research
Wounds & treatments
Skin-loss wounds
How wounds heal
Current wound treatments
Chronic wounds
Technology
Tissue Scaffolds
ProMatrix technology
Manufacturing platform
Modelling & Digital twin
Research Services
SCANNING ELECTRON MICROSCOPY (SEM)
Scaffolds for Research
News
INVESTORS
contact
Julian Dye
8 August 2024

Oxartis wins an IUK RTC award for clean-room manufacturing

Julian Dye
8 August 2024

8th August 2024

Oxartis has signed an agreement to collaborate with MTIF, Medical Technology Innovation Facility, Nottingham Trent University, to initiate cleanroom manufacture of ProMatrix BioDerm, our first tissue regeneration product, for scarless reconstruction of full-thickness skin loss wounds.

Newer PostOxartis Team Presents at Advanced Therapies March 2024
Older PostOXARTIS TEAMS UP WITH UCL FOR INNOVATE UK BIOMEDICAL CATALYST PROJECT
Back to Top
Oxartis Ltd, Heyford Park Innovation Centre, 77 Heyford Park, Bicester, England, OX25 5HD, United Kingdom+447877159254julian@oxartis.co.uk